Jin, M.; Zeng, B.; Liu, Y.; Jin, L.; Hou, Y.; Liu, C.; Liu, W.; Wu, H.; Chen, L.; Gao, Z.;
et al. Co-Delivery of Repurposing Itraconazole and VEGF siRNA by Composite Nanoparticulate System for Collaborative Anti-Angiogenesis and Anti-Tumor Efficacy against Breast Cancer. Pharmaceutics 2022, 14, 1369.
https://doi.org/10.3390/pharmaceutics14071369
AMA Style
Jin M, Zeng B, Liu Y, Jin L, Hou Y, Liu C, Liu W, Wu H, Chen L, Gao Z,
et al. Co-Delivery of Repurposing Itraconazole and VEGF siRNA by Composite Nanoparticulate System for Collaborative Anti-Angiogenesis and Anti-Tumor Efficacy against Breast Cancer. Pharmaceutics. 2022; 14(7):1369.
https://doi.org/10.3390/pharmaceutics14071369
Chicago/Turabian Style
Jin, Mingji, Bowen Zeng, Yanhong Liu, Lili Jin, Yan Hou, Chao Liu, Wei Liu, Hao Wu, Liqing Chen, Zhonggao Gao,
and et al. 2022. "Co-Delivery of Repurposing Itraconazole and VEGF siRNA by Composite Nanoparticulate System for Collaborative Anti-Angiogenesis and Anti-Tumor Efficacy against Breast Cancer" Pharmaceutics 14, no. 7: 1369.
https://doi.org/10.3390/pharmaceutics14071369
APA Style
Jin, M., Zeng, B., Liu, Y., Jin, L., Hou, Y., Liu, C., Liu, W., Wu, H., Chen, L., Gao, Z., & Huang, W.
(2022). Co-Delivery of Repurposing Itraconazole and VEGF siRNA by Composite Nanoparticulate System for Collaborative Anti-Angiogenesis and Anti-Tumor Efficacy against Breast Cancer. Pharmaceutics, 14(7), 1369.
https://doi.org/10.3390/pharmaceutics14071369
